Literature DB >> 9927188

Cell cycle regulation of the double stranded RNA activated protein kinase, PKR.

M Zamanian-Daryoush1, S D Der, B R Williams.   

Abstract

The interferon (IFN)-induced, double stranded RNA (dsRNA)-activated serine/threonine kinase, PKR, is a potent negative regulator of cell growth when overexpressed in yeast or mammalian cells. To determine whether endogenous PKR plays a role in cell growth control, we have investigated the regulation of PKR levels and activity during the cell cycle in human glioblastoma T98G cells. The steady-state level of PKR mRNA in T98G cells was highest in growth arrested cells, dropped sharply within 3 h of serum stimulation then gradually increased as cells progressed through G1, reaching a plateau in early S phase. PKR protein level increased following serum stimulation reaching a peak at the G2+M boundary and declining thereafter. In contrast, PKR kinase activity exhibited two peaks, in early G1 and at the G1/S boundary, declining sharply in early S phase. Thus, the activity profile did not follow the protein profile indicating a tight regulation of PKR at the level of activity. In T98G cells expressing the catalytically inactive PKRK296R the dsRNA-induced activation of NF-kappaB and IRF-1 was suppressed and the mutant cells exhibited resistance to stress induced apoptosis. Cell cycle distribution analysis showed that the mutant expressing cells exhibited longer G1 phase and fewer cells engaged in S phase. Furthermore, early passage mouse embryo fibroblasts derived from PKR knockout mice grew more slowly compared with the control cells. Taken together these results suggest that PKR may play a role in cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927188     DOI: 10.1038/sj.onc.1202293

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

2.  PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53.

Authors:  Cheol-Hee Yoon; Eun-Soo Lee; Dae-Seog Lim; Yong-Soo Bae
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-24       Impact factor: 11.205

3.  NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase.

Authors:  M Zamanian-Daryoush; T H Mogensen; J A DiDonato; B R Williams
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

4.  The B56alpha regulatory subunit of protein phosphatase 2A is a target for regulation by double-stranded RNA-dependent protein kinase PKR.

Authors:  Z Xu; B R Williams
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

5.  Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities.

Authors:  Kyung-Soo Chang; Zhaohui Cai; Chen Zhang; Ganes C Sen; Bryan R G Williams; Guangxiang Luo
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

6.  The protein activator of protein kinase R, PACT/RAX, negatively regulates protein kinase R during mouse anterior pituitary development.

Authors:  Benjamin K Dickerman; Christine L White; Patricia M Kessler; Anthony J Sadler; Bryan R G Williams; Ganes C Sen
Journal:  FEBS J       Date:  2015-10-26       Impact factor: 5.542

7.  Activation of NF-kappaB in cells productively infected with HSV-1 depends on activated protein kinase R and plays no apparent role in blocking apoptosis.

Authors:  Brunella Taddeo; Ting Rong Luo; Weiran Zhang; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

8.  Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.

Authors:  M Gale; B Kwieciszewski; M Dossett; H Nakao; M G Katze
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Retinol supplements antiviral action of interferon in patients with chronic hepatitis C: a prospective pilot study.

Authors:  Naruaki Kohge; Shuichi Sato; Sachiko Hamamoto; Shuji Akagi; Yasushi Uchida; Tatsuya Miyake; Tomoko Mishiro; Kohichiro Furuta; Naoki Oshima; Junnichi Ishine; Yoshiko Takahashi; Norihisa Ishimura; Ryo Fukuda; Shunji Ishihara; Yuji Amano; Yoshikazu Kinoshita
Journal:  J Clin Biochem Nutr       Date:  2009-12-29       Impact factor: 3.114

10.  PKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone.

Authors:  Ana Maria Rivas-Estilla; Yuri Svitkin; Marcelo Lopez Lastra; Maria Hatzoglou; Averell Sherker; Antonis E Koromilas
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.